Muir-Torre syndrome in a haemodialysis patient

被引:0
作者
Godfrey, Evonne D. [1 ]
Coward, Robert A. [1 ]
Gharpuray-Pandit, Deepa [2 ]
Lalloo, Fiona [3 ]
McKirdy, Stuart [4 ]
Woywodt, Alexander [1 ]
机构
[1] Lancashire Teaching Hosp NHS Fdn Trust, Dept Renal Med, Preston, Lancs, England
[2] Lancashire Teaching Hosp NHS Fdn Trust, Dept Pathol, Preston, Lancs, England
[3] MAHSC, St Marys Hosp, Genet Med, Manchester, Lancs, England
[4] Lancashire Teaching Hosp NHS Fdn Trust, Plast Surg, Preston, Lancs, England
来源
CLINICAL KIDNEY JOURNAL | 2013年 / 6卷 / 04期
关键词
Muir-Torre syndrome; sebaceous cell carcinoma;
D O I
10.1093/ckj/sft068
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Muir-Torre syndrome (MTS) is a rare inherited cancer syndrome with variable penetrance. MTS follows an autosomal-dominant pattern of inheritance, and is a subtype of Lynch syndrome [formally known as hereditary non-polyposis colorectal cancer (HNPCC)]. MTS is caused by mutations in one of several mismatch repair genes. Patients typically present with sebaceous neoplasms (sebaceous adenoma, sebaceous epithelioma, or sebaceous carcinoma) or with multiple keratoacanthomas. These patients also have an increased lifetime risk of visceral malignancies, typically affecting the colon, ovary, endometrium, genitourinary tract and small bowel. We describe a case of MTS in a haemodialysis patient and implications for transplant listing.
引用
收藏
页码:414 / 417
页数:4
相关论文
共 30 条
[1]   Sebaceous carcinoma of the skin of the breast: A case report [J].
Alzaraa A. ;
Ghafoor I. ;
Yates A. ;
Dhebri A. .
Journal of Medical Case Reports, 2 (1)
[2]   Sebaceous carcinoma: the great masquerader [J].
Buitrago, William ;
Joseph, Aaron K. .
DERMATOLOGIC THERAPY, 2008, 21 (06) :459-466
[3]  
COHEN PR, 1991, AM J MED, V90, P606
[4]   Estimated Radiation Exposure from Medical Imaging in Hemodialysis Patients [J].
De Mauri, Andreana ;
Brambilla, Marco ;
Chiarinotti, Doriana ;
Matheoud, Roberta ;
Carriero, Alessandro ;
De Leo, Martino .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (03) :571-578
[5]   Incidence of Cutaneous Sebaceous Carcinoma and Risk of Associated Neoplasms Insight Into Muir-Torre Syndrome [J].
Dores, Graca M. ;
Curtis, Rochelle E. ;
Toro, Jorge R. ;
Devesa, Susan S. ;
Fraumeni, Joseph F., Jr. .
CANCER, 2008, 113 (12) :3372-3381
[6]   Diagnosis and management of sebaceous carcinoma: An Australian experience [J].
Dowd, Michael B. ;
Kumar, Rohit J. ;
Sharma, Raghwa ;
Murali, Rajmohan .
ANZ JOURNAL OF SURGERY, 2008, 78 (03) :158-163
[7]   Muir-Torre syndrome - Treatment with isotretinoin and interferon alpha-2a can prevent tumour development [J].
Graefe, T ;
Wollina, U ;
Schulz, HJ ;
Burgdorf, W .
DERMATOLOGY, 2000, 200 (04) :331-333
[8]   MUIR-TORRE SYNDROME - A VARIANT OF THE CANCER FAMILY SYNDROME [J].
HALL, NR ;
WILLIAMS, MAT ;
MURDAY, VA ;
NEWTON, JA ;
BISHOP, DT .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (08) :627-631
[9]   Screening, diagnosis, and treatment of cancer in long-term dialysis patients [J].
Holley, Jean L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (03) :604-610
[10]   Renal neoplasias in patients receiving dialysis and renal transplantation: Clinico-pathological features and P53 gene mutations [J].
Hoshida, Y ;
Nakanishi, H ;
Shin, M ;
Satoh, T ;
Hanai, J ;
Aozasa, K .
TRANSPLANTATION, 1999, 68 (03) :385-390